Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?

E-ISSN： 1873-4286|20|17|2881-2898

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2881-2898

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine Sutterlüüty Hedwig Grusch Michael Grasl-Kraupp Bettina Berger Walter Marian Brigitte

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

The insulin-like growth factor-I receptor as a target for cancer therapy

By Baserga Renato

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 753-768

Informa Healthcare

Access to resources Recommend Favorite

Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?

By Bedussi Francesca Bottini Alberto Memo Maurizio Fox Stephen B Sigala Sandra Generali Daniele

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 665-678

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 865-874

Bentham Science Publishers

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite